SCS Hf 10 Burst denied as not FDA-approved for this use by Aetna?

Aetna's specific coverage criteria for scs hf10 burst are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denied This — and Why You Can Fight Back

Aetna may issue a "not FDA-approved" denial for high-frequency (HF10) or burst-mode spinal cord stimulation when its reviewers classify the specific waveform or programming modality as investigational, even though the underlying device platform carries FDA clearance. This happens because insurers sometimes distinguish between the cleared device and a particular stimulation parameter set, treating the latter as a separate unapproved intervention. It is a legally appealable denial.

## The Regulatory Reality

HF10 and burst spinal cord stimulation systems have received FDA clearance through the 510(k) premarket pathway. Before drafting your appeal, obtain the device's FDA clearance letter (available on the FDA 510(k) database) and the manufacturer's Instructions for Use, which document the cleared indications. Your appeal should affirmatively cite the clearance number and attach these documents to rebut any claim that the device or waveform is unapproved.

## Your Federal Appeal Rights

If your plan is an ACA-compliant fully-insured plan, you are entitled to an external review under ACA §2719 after exhausting internal appeals. If your plan is self-funded under ERISA, you have the right to a full-and-fair review under ERISA §503, and most self-funded plans also offer external review. The external-review window is generally within four months of the denial notice — do not let that deadline pass. If waiting for the standard timeline would seriously jeopardize your health, you can request an expedited review, which carries a 72-hour turnaround.

## Appeal Timeline

1. Level 1 internal appeal — submit within the plan's stated deadline (typically 180 days of the denial). 2. Level 2 internal appeal — if the plan offers one, exhaust it promptly. 3. External review — request immediately after final internal denial, within the four-month window.

## Documentation to Gather

• Diagnosis confirmation: operative notes, imaging, and treating physician's documentation of the underlying pain condition.
• Prescriber medical-necessity letter: a detailed letter from the implanting physician explaining why this specific stimulation modality is medically necessary for your condition, citing the relevant guideline organization (such as applicable neuromodulation society guidelines) without relying on bare opinion.
• FDA clearance documentation: 510(k) clearance letter and labeled indications for the specific device.
• Prior-treatment history: a chronological list of all prior conservative and interventional treatments tried, with dates and documented outcomes.
• Peer-reviewed literature: published evidence supporting the modality for your diagnosis, which your physician can help identify.

## Criteria-Mapping Structure

Pull Aetna's published Clinical Policy Bulletin for spinal cord stimulation and list every coverage criterion. For each criterion, write the exact supporting fact from your medical record on the same line. Submit this as a table. Reviewers are required to address each item, making it far harder to sustain a blanket denial.